Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

FBG, your frustration is precisely the goal of the short manipulation. You say that the reason Dan should be faulted is that the share price is below the average of the offering prices, and then you look for a substantive reason for that. But the only reason you can come up with is what? The fact that the company decided to raise money in August on the strength of the Amgen deal. Well, if the pps is fair valuation, then Dan did great, right, in getting a higher price for the placement. But the current valuation is not warranted, and you know it.